cdmo.directory
← Compare landing

Adragos Pharma vs IDT Australia

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAdragos PharmaIDT Australia
SummaryGlobal CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.IDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support.
Services
  • HPAPI Manufacturing (High-Potency)
  • Monoclonal Antibody (mAb) Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Topical & Semi-Solid Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Secondary Packaging & Labeling
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
  • Regulatory Affairs
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Oral Solid Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • Secondary Packaging & Labeling
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
Development capabilities
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Analytical method development
  • Formulation development
  • ICH stability testing
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Prefilled Syringes (PFS)
  • Oral Solid Dose (OSD)
  • Expression: Mammalian
  • HPAPI
  • DEA licensed
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Oral Solid Dose (OSD)
  • HPAPI
  • DEA licensed
Locations
  • Headquarters, Munich, Bavaria, Germany
  • Development & Manufacturing, Athens, Attica, Greece
  • Manufacturing, Halden, Østfold, Norway
  • Manufacturing, Jura, Bourgogne-Franche-Comté, France
  • Manufacturing, Kawagoe, Saitama, Japan
  • Manufacturing, Livron, Auvergne-Rhône-Alpes, France
  • Manufacturing, Leipzig, Saxony, Germany
  • Manufacturing, Maisons-Alfort, Île-de-France, France
  • Headquarters, Australia
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Adragos Pharma alternatives · IDT Australia alternatives

Markdown mirror: /compare/adragos-pharma/idtaus-com.md